HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Eurelings Selected Research

Polyneuropathies (Polyneuropathy)

2/2010Prognosis of polyneuropathy due to IgM monoclonal gammopathy: a prospective cohort study.
9/2009Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.
9/2009Rituximab for polyneuropathy with IgM monoclonal gammopathy.
7/2007Intermittent cyclophosphamide with prednisone versus placebo for polyneuropathy with IgM monoclonal gammopathy.
12/2006Neurologic and hematologic response to fludarabine treatment in IgM MGUS polyneuropathy.
6/2005Malignant transformation in polyneuropathy associated with monoclonal gammopathy.
9/2003Increase of sural nerve T cells in progressive axonal polyneuropathy and monoclonal gammopathy.
2/2002Sural nerve T cells in demyelinating polyneuropathy associated with monoclonal gammopathy.
11/2001Antiganglioside antibodies in polyneuropathy associated with monoclonal gammopathy.
10/2001MRI of the brachial plexus in polyneuropathy associated with monoclonal gammopathy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Eurelings Research Topics

Disease

11Polyneuropathies (Polyneuropathy)
02/2010 - 01/2001
10Paraproteinemias (Monoclonal Gammopathy)
02/2010 - 01/2001
5Neoplasms (Cancer)
01/2016 - 10/2001
3Peripheral Nervous System Diseases (PNS Diseases)
01/2016 - 02/2013
2Multiple Myeloma
01/2016 - 10/2001
2Weight Loss (Weight Reduction)
06/2005 - 10/2001
2Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
02/2002 - 10/2001
2Hematologic Neoplasms (Hematological Malignancy)
02/2002 - 10/2001
1Demyelinating Diseases (Demyelinating Disease)
02/2010
1Fever (Fevers)
06/2005
1Vasculitis (Vasculitides)
09/2003
1Botulism
12/2001
1Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2001
1Castleman Disease (Castleman's Disease)
10/2001
1Plasmacytoma
10/2001
1POEMS Syndrome (Syndrome, POEMS)
10/2001
1Neurologic Manifestations (Neurological Manifestations)
01/2001

Drug/Important Bio-Agent (IBA)

10Immunoglobulin M (IgM)IBA
02/2010 - 01/2001
6AntibodiesIBA
02/2010 - 01/2001
4Immunoglobulin G (IgG)IBA
09/2003 - 10/2001
3Myelin-Associated GlycoproteinIBA
09/2009 - 01/2001
2Prednisone (Sone)FDA LinkGeneric
07/2007 - 09/2003
2Proteins (Proteins, Gene)FDA Link
06/2005 - 10/2001
1Rituximab (Mabthera)FDA Link
09/2009
1Monoclonal AntibodiesIBA
09/2009
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2007
1fludarabineIBA
12/2006
1oblimersen (G3139)IBA
06/2004
1Ethylene Glycol (Monoethylene Glycol)IBA
12/2001
1Immunoglobulin A (IgA)IBA
11/2001
1GangliosidesIBA
11/2001
1sulfate-3-glucuronyl paraglobosideIBA
01/2001
1paragloboside (neolactotetraosylceramide)IBA
01/2001
1Sulfoglycosphingolipids (Sulfatides)IBA
01/2001

Therapy/Procedure

4Drug Therapy (Chemotherapy)
01/2016 - 06/2004